Cited by 8Renal Diseases and GlomerulopathiesChronic Kidney Disease and DiabetesLipid metabolism and disorders

A newborn infant with lipoprotein glomerulopathy associated with congenital nephrotic syndrome

Open access
Shimizu, Masaki, Ohno, Tsutomu, Kimoto, Hirohumi, Hosono, Shigeharu, Nozawa, Masayo·2001·Pediatrics International

Abstract

Lipoprotein glomerulopathy (LPG) is considered to result from the formation of thrombi of abnormal lipoproteins in the glomeruli.[1][2][3][4] The etiology of the disease remains unknown, although apolipoprotein may have a role.[5][6][7] The disease has been reported almost exclusively in adults in Japan.1,2 In the current report, we present a neonatal case of LPG manifested with a congenital nephrotic syndrome.To our knowledge, this is the youngest reported case of this disease.8,9

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1442-200x.2001.01344.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Lipoprotein glomerulopathy has a wide age distribution, occurring in patients aged 4-69 years, with recent cases also reported in newborns and people in their seventies.

    “LPG has a wide range of age distribution, and occurs in all patients aged 4–69 years old. However, recent cases have also been reported in newborn baby and people in their seventies [28].”

    From A novel apolipoprotein E mutation, ApoE Ganzhou (Arg43Cys), in a Chinese son and his father with lipoprotein glomerulopathy: two case reports (2022) · cites this paper as [28]

    The Abstract and Conclusions report a neonatal case of lipoprotein glomerulopathy, supporting the newborn portion of the claim. Our copy does not give a 4–69-year age range or report cases in people in their seventies (searched for the age range and older patients). (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 8

  1. Saito T, Oikawa S, Sato H, Chiba J. Lipoprotein glomerulo- pathy and its pathogenesis. Contrib. Nephrol. 1997; 120: 30-8.
  2. Shibata T, Kaneko N, Hara Y, Saito T, Sakaguchi H. A case of lipoprotein glomerulopathy: Light and electron microscopic observations of the glomerulus. Acta Pathol. Jpn. 1990; 40: 448-57.
  3. Horita K, Eto M, Makino I et al. Apolipoprotein E 2 , renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus. Atherosclerosis 1994; 107: 203-11.
  4. Komatsu T, Kanatsu K, Ochi H, Kita T, Doi T. Lipoprotein glomerulopathy with a new apolipoprotein E phenotype. Am. J. Kidney Dis. 1995; 25: 952-3.
  5. Oikawa S, Suzuki N, Sakuma E et al. Abnormal lipoprotein pattern in lipoprotein glomerulopathy. Am. J. Kidney Dis. 1991; 18: 553-8.
  6. Koitabashi Y, Ikoma M, Miyahira T et al. Long-term follow- up of a paediatric case of lipoprotein glomerulopathy. Pediatr. Nephrol. 1991; 4: 122-8.
  7. Maruyama K, Arai H, Ogawa T, Tomizawa S, Morikaea A. Lipoprotein glomerulopathy: A pediatric case report. Pediatr. Nephrol. 1997; 11: 213-14.
  8. Juhani R, Niilo PH, Niilo H. Congenital and infantile nephrotic syndrome. In: Chester Jr ME (ed.). Pediatric Kidney Disease. Little, Brown, Boston, 1992; 1291-305.

Cited by

Sorted by citations

Authors
Shimizu, M., Ohno, T., Kimoto, H., Hosono, S., & Nozawa, M.
Affiliations
Saitama Children's Medical Center (JP)
Corresponding author
Shimizu, Masaki
Venue
Pediatrics International
Publisher
Wiley
Published
2001-02-28
Volume
43
Issue
1
Pages
78-80
ISSN
  • 1328-8067 (ISSN-L)
  • 1442-200X
OpenAlex
W2102608546
Cited by
8
References
3
Citations by year
2022: 2 · 2019: 1 · 2016: 1
FWCI
0.48
Type
journal article
Language
en
Open access
Locations
  • Pediatrics International (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
lipoprotein glomerulopathy, congenital nephrotic syndrome, apolipoproteins
MeSH terms
Humans, Hyperlipidemias, Infant, Newborn, Intensive Care Units, Neonatal, Kidney Diseases, Kidney Glomerulus, Lipoproteins, Male, Nephrectomy, Nephrotic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review